Single-center 'real life experience' with pembrolizumab (PEMBRO) in advanced melanoma patients and analysis of baseline factors that correlate with outcome

Y. Jansen, M. Schreuer, B. Neyns

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Article numberP045
Pages (from-to)E33-E34
Number of pages2
JournalMelanoma Research
Volume26
Publication statusPublished - Aug 2016
EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States
Duration: 2 Jun 20167 Jun 2016

Cite this